1. Home
  2. PIPR vs GRFS Comparison

PIPR vs GRFS Comparison

Compare PIPR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$355.03

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.20

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIPR
GRFS
Founded
1895
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.0B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
PIPR
GRFS
Price
$355.03
$9.20
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$362.50
$10.15
AVG Volume (30 Days)
116.5K
563.8K
Earning Date
01-30-2026
01-01-0001
Dividend Yield
1.63%
1.56%
EPS Growth
42.49
N/A
EPS
13.30
0.64
Revenue
$1,717,433,000.00
$8,821,017,248.00
Revenue This Year
$17.11
$5.46
Revenue Next Year
$15.11
$5.60
P/E Ratio
$26.79
$17.68
Revenue Growth
13.46
7.31
52 Week Low
$202.91
$6.19
52 Week High
$374.77
$11.14

Technical Indicators

Market Signals
Indicator
PIPR
GRFS
Relative Strength Index (RSI) 60.25 57.67
Support Level $332.48 $8.81
Resistance Level $372.75 $9.22
Average True Range (ATR) 10.17 0.26
MACD 3.78 0.08
Stochastic Oscillator 66.22 95.25

Price Performance

Historical Comparison
PIPR
GRFS

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: